Atypical hemolytic‐uremic syndrome after COVID‐19 vaccine: A case report

Abstract Background The emergence of new SARS‐CoV‐2 variants and the global COVID‐19 pandemic spurred urgent vaccine development. While common vaccine side effects are well‐documented, rare adverse events necessitate post‐marketing surveillance. Recent research linked messenger RNA vaccines to throm...

Full description

Bibliographic Details

Published in:	Immunity, Inflammation and Disease
Main Authors:	Marcos Adriano Garcia Campos, Rômullo José Costa Ataídes, Maxwell Cabral Ferreira, Adriano Soares Alves, Gyl Eanes Barros Silva
Format:	Article
Language:	English
Published:	Wiley 2024-07-01
Subjects:	atypical hemolytic‐uremic syndrome case report post‐COVID‐19 thrombotic microangiopathy
Online Access:	https://doi.org/10.1002/iid3.1270